Comparing Therapeutic versus Prophylactic Enoxaparin Therapy in Severe COVID-19 Patients: A Randomized Clinical Trial.

Samira KafanMohammad Reza FattahiMahsa Akhbari ShojaeiAida Hossein NezhadMahshid ImankhanDavoud JahansouzMahnaz MontazeriAzar HadadiSara FattahiArad IranmehrMarzieh PazokiHormat Rahimzadeh

Published in: Medical journal of the Islamic Republic of Iran (2023)

The results of the current study were in favor of anticoagulant treatment with prophylactic doses of enoxaparin. Still, due to the limitations of this paper, we suggest that these findings be treated cautiously.

Keyphrases

venous thromboembolism
sars cov
atrial fibrillation
early onset
stem cells
replacement therapy
newly diagnosed